Latodine 10 mg (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 8 weeks, most ulcers healed within 8 weeks; however, healing time may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 6 weeks, most ulcers healed within 6 weeks; however, healing time may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. In clinical trials in which treatment was given for up to 2 weeks, most lesions healed within 2 weeks; however, healing time may occasionally vary from patient to patient. 4. Concomitant antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 days or 14 days. 5. Premedication before anesthesia: The usual dose is 10mg of lafutidine per dose, administered orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine per dose twice daily.

This medication should not be used in patients with known allergies to its components. This medication contains lactose; therefore, patients with lactose intolerance or specific genetic metabolic disorders should avoid taking it. Caution should be exercised in patients who have had hypersensitivity reactions to the drug, have liver or kidney dysfunction, are undergoing dialysis, and in elderly patients. This medication can rarely cause severe allergic reactions, liver dysfunction, and blood cell depletion; if symptoms occur, the medication should be discontinued immediately and a doctor consulted. Mild side effects can occur in various systems such as the gastrointestinal tract, central nervous system, and circulatory system, so any abnormal symptoms should be reported. This medication may mask symptoms of malignant tumors or delay diagnosis, so any suspicious symptoms should be thoroughly investigated. Elderly patients may have decreased physical function, therefore dosage adjustment and monitoring of condition are necessary. Dialysis patients may experience increased drug concentration in the blood, so administration should start with a low dose and be done slowly. Pregnant women or women of childbearing potential should take this medication with caution under medical guidance, and nursing women are advised not to take it. Safety in children has not been established; therefore, its use is not recommended. The medication must be kept out of reach of children and should be stored in its original container to maintain quality. Animal studies have not shown carcinogenicity, but some side effects have been observed at high doses, and no serious effects on the fetus have been reported.

• Shock
• Symptoms of Anaphylaxis
• Facial Pallor
• Hypotension
• Generalized Rash
• Dyspnea
• Liver Dysfunction
• Jaundice
• Agranulocytosis
• Pharyngitis

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. It is advisable to maintain storage temperature between 1°C and 30°C at room temperature to safely preserve the drug's effectiveness.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle